Ken O'Connell
Directeur Général chez Longboat Clinical Ltd.
Profil
Ken O'Connell currently works at Longboat Clinical Ltd., as Chief Executive Officer & Director, biologit, as Director from 2023, and Advarra, Inc., as President-Technology & Professional Services.
Postes actifs de Ken O'Connell
| Sociétés | Poste | Début |
|---|---|---|
Longboat Clinical Ltd.
 Longboat Clinical Ltd. Packaged SoftwareTechnology Services Longboat Clinical Ltd. develops software for doctors to interact with patients through online. It specializes in clinical trials, protocol compliance, investigator site engagement, protocol-specific training, investigator meetings, and patient engagement. The company is headquartered in Dublin, Ireland. | Directeur Général | - |
Advarra, Inc.
 Advarra, Inc. Miscellaneous Commercial ServicesCommercial Services Advarra, Inc. engages in the provision of integrated research compliance solutions. It offers institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services. It also covers GxP/GCP auditing and compliance, regulatory, clinical quality and assurance, research administration and human research protection (HRP), and data protection and technology compliance. The company was founded in 1983 and is headquartered in Columbia, MD. | Directeur Technique/Scientifique/R&D | - |
biologit
 biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Directeur/Membre du Conseil | 01/03/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Longboat Clinical Ltd.
Longboat Clinical Ltd. Packaged SoftwareTechnology Services Longboat Clinical Ltd. develops software for doctors to interact with patients through online. It specializes in clinical trials, protocol compliance, investigator site engagement, protocol-specific training, investigator meetings, and patient engagement. The company is headquartered in Dublin, Ireland. | Technology Services |
Advarra, Inc.
Advarra, Inc. Miscellaneous Commercial ServicesCommercial Services Advarra, Inc. engages in the provision of integrated research compliance solutions. It offers institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services. It also covers GxP/GCP auditing and compliance, regulatory, clinical quality and assurance, research administration and human research protection (HRP), and data protection and technology compliance. The company was founded in 1983 and is headquartered in Columbia, MD. | Commercial Services |
biologit
biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Technology Services |